Are new drugs cost-effective for patients undergoing ambulatory surgery?
White
P F
PF
Watcha
M F
MF
D000556:Ambulatory Surgical Procedures; D000700:Analgesics / Q000191:economics*; D003362:Cost-Benefit Analysis; D006801:Humans; D020910:Ketorolac; D017294:Ondansetron / Q000191:economics*; D014046:Tolmetin / Q000031:analogs & derivatives* / Q000191:economics; D014481:United States
D000700:Analgesics; D017294:Ondansetron; D014046:Tolmetin; D020910:Ketorolac